Get the Stockscreener App
1.89
94.44%
-32.08
After Hours:
1.89
Meridian Bioscience Inc. Stock (VIVO) Forecast
The Meridian Bioscience Inc. (VIVO) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $32.99, representing a +1,645% increase from the current price of $1.89. The highest analyst price target is $35.29, and the lowest is $30.68.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month VIVO Price Target
Average 36.24
(+1,817% Upside)
Is Meridian Bioscience Inc. (VIVO) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 0.00 | Neutral |
| STOCH(9,6) | 0.00 | Buy |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | 0.00 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.189
Buy
|
0.00
Buy
|
| MA20 |
0.0945
Buy
|
0.00
Buy
|
| MA50 |
0.0378
Buy
|
0.00
Buy
|
| MA100 |
0.0189
Buy
|
0.00
Buy
|
| MA200 |
0.00945
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, VIVO could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on VIVO, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 0 indicates that VIVO is oversold. This indicates that VIVO price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 0 indicates that VIVO is oversold. This indicates that VIVO price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that VIVO is oversold. This suggests that VIVO price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 0 indicates that VIVO is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term VIVO price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Meridian Bioscience Inc. financial reports and earnings history, Meridian Bioscience Inc. (VIVO) stock could reach $31.73 by 2030, $67.76 by 2040 and $98.72 by 2050. See the projected annual prices until 2050 of the Meridian Bioscience Inc. stock below:
- Meridian Bioscience Inc. (VIVO) is expected to reach an average price of $59.25 in 2035, with a high prediction of $59.91 and a low estimate of $55.54. This indicates an $3,035% rise from the last recorded price of $1.89.
- Meridian Bioscience Inc. (VIVO) stock is projected to chart a bullish course in 2040, with an average price target of $66.29, representing an $3,407% surge from its current level. The forecast ranges from a conservative $64.48 to a sky-high $67.76.
- Our analysts predict Meridian Bioscience Inc. (VIVO) to jump 4,312% by 2045, soaring from $81.42 to an average price of $83.38, potentially reaching $91.82. While $81.42 is the low estimate, the potential upside is significant.
- Meridian Bioscience Inc. (VIVO) stock is expected to climb by 2050, reaching an average of $98.29, a $5,101% jump from its current level. However, a wide range of estimates exists, with high and low targets of $98.72 and $94.33, respectively, highlighting the market's uncertainty.
Meridian Bioscience Inc. Stock (VIVO) Year by Year Forecast
Meridian Bioscience Inc. Stock (VIVO) Price Forecast for 2026
The predicted value for Meridian Bioscience Inc. (VIVO) in 2026 is set at an average of $35.13. Estimates vary from a peak of $42.88 to a trough of $27.37, indicating an +1,759% surge from the present price of $1.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2026 | $35.13 | $30.68 | $35.29 | +1,759% |
| May, 2026 | $36.29 | $32.95 | $42.88 | +1,820% |
| June, 2026 | $38.09 | $32.24 | $38.70 | +1,915% |
| July, 2026 | $35.68 | $34.09 | $42.14 | +1,788% |
| August, 2026 | $31.60 | $30.13 | $35.97 | +1,572% |
| September, 2026 | $33.27 | $29.60 | $34.23 | +1,660% |
| October, 2026 | $34.78 | $32.41 | $35.41 | +1,740% |
| November, 2026 | $33.48 | $29.79 | $35.58 | +1,671% |
| December, 2026 | $33.41 | $31.66 | $33.92 | +1,667% |
Meridian Bioscience Inc. Stock (VIVO) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Meridian Bioscience Inc. (VIVO) is $39.45, with a high forecast of $48.41 and a low forecast of $30.49. This indicates an +1,987% increase from the last price of $1.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $32.27 | $31.67 | $33.70 | +1,608% |
| February, 2027 | $31.71 | $30.80 | $32.78 | +1,578% |
| March, 2027 | $34.80 | $31.12 | $34.80 | +1,741% |
| April, 2027 | $32.86 | $30.49 | $34.79 | +1,639% |
| May, 2027 | $34.20 | $32.47 | $34.76 | +1,710% |
| June, 2027 | $37.45 | $33.34 | $37.58 | +1,881% |
| July, 2027 | $39.11 | $37.20 | $40.72 | +1,969% |
| August, 2027 | $39.62 | $38.11 | $41.11 | +1,997% |
| September, 2027 | $39.36 | $38.27 | $42.43 | +1,983% |
| October, 2027 | $41.74 | $37.26 | $41.89 | +2,108% |
| November, 2027 | $42.45 | $39.83 | $42.93 | +2,146% |
| December, 2027 | $46.56 | $42.60 | $48.41 | +2,363% |
Meridian Bioscience Inc. Stock (VIVO) Price Forecast for 2028
In 2028, Meridian Bioscience Inc. (VIVO) is projected to reach an average price of $40.64, with a high projection of $48.77 and a low estimate of $32.51. This indicates an +2,050% rise from the last price of $1.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $46.85 | $45.17 | $47.12 | +2,379% |
| February, 2028 | $46.83 | $46.60 | $47.82 | +2,378% |
| March, 2028 | $46.12 | $45.49 | $47.58 | +2,340% |
| April, 2028 | $46.40 | $45.88 | $47.18 | +2,355% |
| May, 2028 | $46.43 | $46.12 | $46.87 | +2,357% |
| June, 2028 | $47.82 | $45.72 | $48.25 | +2,430% |
| July, 2028 | $48.45 | $47.75 | $48.51 | +2,463% |
| August, 2028 | $36.42 | $35.25 | $48.77 | +1,827% |
| September, 2028 | $35.90 | $34.16 | $36.69 | +1,799% |
| October, 2028 | $35.98 | $34.87 | $36.20 | +1,804% |
| November, 2028 | $36.31 | $35.81 | $36.88 | +1,821% |
| December, 2028 | $32.54 | $32.51 | $37.47 | +1,622% |
Meridian Bioscience Inc. Stock (VIVO) Price Forecast for 2029
The 2029 price forecast for Meridian Bioscience Inc. Stock (VIVO) is $32.04 on average, with a high prediction of $35.16 and a low estimate of $28.92. This represents an +1,595% increase from the previous price of $1.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $31.52 | $31.17 | $33.60 | +1,568% |
| February, 2029 | $31.50 | $30.87 | $32.08 | +1,567% |
| March, 2029 | $32.23 | $31.37 | $32.42 | +1,605% |
| April, 2029 | $32.64 | $31.64 | $32.88 | +1,627% |
| May, 2029 | $29.95 | $29.79 | $32.76 | +1,484% |
| June, 2029 | $30.47 | $29.78 | $31.08 | +1,512% |
| July, 2029 | $31.10 | $29.88 | $31.24 | +1,545% |
| August, 2029 | $30.00 | $28.92 | $31.53 | +1,487% |
| September, 2029 | $31.12 | $29.88 | $31.30 | +1,547% |
| October, 2029 | $31.31 | $30.88 | $31.78 | +1,557% |
| November, 2029 | $30.30 | $30.20 | $35.16 | +1,503% |
| December, 2029 | $30.10 | $29.27 | $31.55 | +1,492% |
Meridian Bioscience Inc. Stock (VIVO) Price Forecast for 2030
Meridian Bioscience Inc. Stock (VIVO) is expected to reach an average price of $38.68 in 2030, with a high forecast of $49.73 and a low forecast of $27.62. This signifies an +1,946% surge from the last price of $1.89.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $30.65 | $27.62 | $31.73 | +1,522% |
| February, 2030 | $34.46 | $30.51 | $34.70 | +1,723% |
| March, 2030 | $37.48 | $34.13 | $41.17 | +1,883% |
| April, 2030 | $41.57 | $35.86 | $41.97 | +2,100% |
| May, 2030 | $47.74 | $41.55 | $48.40 | +2,426% |
| June, 2030 | $41.34 | $40.07 | $49.73 | +2,087% |
| July, 2030 | $37.07 | $36.35 | $41.78 | +1,861% |
| August, 2030 | $40.75 | $36.78 | $41.41 | +2,056% |
| September, 2030 | $40.91 | $40.72 | $44.00 | +2,065% |
| October, 2030 | $42.88 | $39.30 | $43.35 | +2,169% |
| November, 2030 | $45.06 | $41.49 | $46.05 | +2,284% |
| December, 2030 | $47.30 | $42.78 | $47.46 | +2,403% |
0.38%
1.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):